Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Boston University and Fraunhofer Create Alliance

By Labmedica staff writers
Posted on 30 Nov 2006
Boston University (BU, Boston, MA, USA) and its College of Engineering are joining Fraunhofer Gesellschaft (Munich, Germany) to create the Boston University-Fraunhofer Alliance for Medical Devices, Instrumentation and Diagnostics. More...
BU and Fraunhofer will jointly fund the five-year, U.S.$5 million alliance, which aims to develop arrays for diagnostic applications.

Andrew Sharon, a BU engineering professor and director of the Fraunhofer Center for Manufacturing and Innovation, said that the alliance will create disposable chips for molecular-level disease diagnosis. The firm will fabricate DNA and peptide arrays and perform translational research with the medical school. An optically guided colon-cancer detection and treatment system is a promising innovation also under consideration for initial support by the alliance.

The alliance seeks to take advantage of the two institutions' respective strengths. Advanced biomedical engineering research being conducted throughout BU's College of Engineering, College of Arts and Sciences, and Medical School, generally proceeds to the laboratory bench level. Fraunhofer hopes to take these innovations and convert them into working medical devices and instruments that can be licensed to existing companies or new, spin-off ventures.

Fraunhofer Gesellschaft is very active in biomedical research. Current activities include array-based diagnostics, medical imaging, surgical micro-tools development, and other novel devices and instrumentation. The Fraunhofer Center for Manufacturing Innovation was established at Boston University in 1994. The center scales up basic research into advanced industrial technologies that meet the needs of client companies both locally and globally.



Related Links:
Boston University
Fraunhofer Gesellschaft

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.